← Open Payments lookup

LANCE KORTESOJA: Open Payments

NPI 1114497930 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$607 in 32 payments from 12 companies in 2025. Trend: 2023 $358 · 2024 $622 · 2025 $607

Food & beverage: $607
CompanyPaymentsAmount
Novo Nordisk Inc6$115
Abbott Laboratories6$104
PFIZER INC.4$79
Otsuka America Pharmaceutical, Inc.3$68
ABBVIE INC.4$60
Boehringer Ingelheim Pharmaceuticals, Inc.2$45
GlaxoSmithKline, LLC.2$31
Gilead Sciences, Inc.1$29
Dexcom, Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20

Products named: FREESTYLE LIBRE 3, REXULTI, Wegovy, VRAYLAR, ELIQUIS, NURTEC ODT, SHINGRIX, Ozempic.

Industry payments across MI — which companies pay providers there.